- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
EXELON TRANSDERMAL PATCH 15 - 13.3mg/24h - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N06DA03 | B | Rivastigmine - 13.3mg/24h | 8491 | 112415/1 | EXELON TRANSDERMAL PATCH 15 | 13.3mg/24h | 30 | Patch | Transdermal | Khalil Fattal & Fils S.A.L. | LTS Lohmann Therapie System AG | Germany | 7,582,922 L.L | 21.26 | C | Novartis Pharma AG, Basle | Switzerland | 2/5/2024 | 0 |